EPO Patents = 1

Forward Citations = 16

Loading Chart...

3 inventors (with patents filed for the assignee):

Robin Parish Hyde-Deruyscher (5 out of 9 patents)

Nancy Harlan Hyde-DeRuyscher (4 out of 5 patents)

Elicia Kristine Hyde-DeRuyscher (4 out of 5 patents)

5 patents: Sort by Forward Citations

1. 11478463 - Mast cell stabilizers for treatment of chronic inflammatory conditions (2022-10-25),

2. 11072648 - Mast cell stabilizers for treatment of fever (2021-07-27),

3. 10501527 - Mast cell stabilizers for treatment of hypercytokinemia and viral infection (2019-12-10),

4. 10494420 - Mast cell stabilizers for treatment of hypercytokinemia and viral infection (2019-12-03),

5. 10160796 - Mast cell stabilizers for treatment of hypercytokinemia and viral infection (2018-12-25),

Emergo Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative treatments for infectious diseases. With a strong commitment to research and development, Emergo aims to bring new therapies to market that address unmet medical needs and improve patient outcomes. The company's pipeline includes promising candidates for various infectious diseases, with a focus on finding solutions for antibiotic-resistant strains.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

5 Patents

#120 in Durham, NC

#1,099 in North Carolina

#50,255 in US

Durham, NC, United States of America

Emergo Therapeutics, Inc.

Forward Citations = 16

3 inventors:

Robin Parish Hyde-Deruyscher (5 out of 9 patents)

Nancy Harlan Hyde-DeRuyscher (4 out of 5 patents)

Elicia Kristine Hyde-DeRuyscher (4 out of 5 patents)

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com